Expertise in
5
conditions

Francois-xavier X. Lescure

Paris, FR 
Expertise in
5
conditions
Paris, FR 

Overview

Francois-xavier Lescure practices practicing medicine in Paris, France.

Lescure is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), Monkeypox, COVID-19, and Pneumonia.

They are actively involved in clinical research, co-authoring 132 peer reviewed articles and participating in 2 clinical trials.

Locations

Paris, France
Other Locations
Saint-claude-de-diray, France
Garches, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Other, Drug
Study Drugs: Remdesivir, Lopinavir, Ritonavir, Interferon Beta-1A, Hydroxychloroquine, AZD7442
Study Phase: Phase 3
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

132 Total Publications

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.
Journal: The Journal of antimicrobial chemotherapy
Published: July 03, 2026

Frequently Asked Questions about Francois-xavier X. Lescure

Is Francois-xavier X. Lescure a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Francois-xavier X. Lescure is classified as an Advanced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Francois-xavier X. Lescure participate in research or clinical trials?

Yes. Francois-xavier X. Lescure has published 132 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Francois-xavier X. Lescure's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lescure's expertise for a condition
ConditionClose
      View All 24 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile